Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series.

about

Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series.

Item

http://www.wikidata.org/entity/Q40964546

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Long-term Management of Modera ...... ith Etanercept: A Case Series.

@en

type

Item

label

Long-term Management of Modera ...... ith Etanercept: A Case Series.

@en

prefLabel

Long-term Management of Modera ...... ith Etanercept: A Case Series.

@en

P1476

Long-term Management of Modera ...... ith Etanercept: A Case Series.

@en

P2093

Jennifer Shelton

http://www.w3.org/2001/XMLSchema#string

Kirk Barber

http://www.w3.org/2001/XMLSchema#string

Marc Bourcier

http://www.w3.org/2001/XMLSchema#string

Melanie Poulin-Costello

http://www.w3.org/2001/XMLSchema#string

Wayne P Gulliver

http://www.w3.org/2001/XMLSchema#string

Yves Poulin

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Pathogenesis and therapy of psoriasis.

Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.

Psoriasis prevalence among adults in the United States.

Epidemiology of psoriatic arthritis in the population of the United States.

Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.

P304

561-569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1203475415584511

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kim A. Papp

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25951825

http://www.w3.org/2001/XMLSchema#string